ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 168 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $139,150 | -14.7% | 30,250 | +19.8% | 0.04% | -7.7% |
| Q2 2023 | $163,115 | -9.7% | 25,250 | +5.4% | 0.04% | -15.2% |
| Q1 2023 | $180,696 | -25.6% | 23,965 | 0.0% | 0.05% | -32.4% |
| Q4 2022 | $242,765 | +11.8% | 23,965 | +9.1% | 0.07% | -2.9% |
| Q3 2022 | $217,234 | -2.6% | 21,965 | +4.8% | 0.07% | 0.0% |
| Q2 2022 | $223,000 | +35.2% | 20,965 | +23.6% | 0.07% | +62.8% |
| Q1 2022 | $165,000 | -1.8% | 16,965 | +44.8% | 0.04% | 0.0% |
| Q4 2021 | $168,000 | – | 11,715 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCVC Bio GP, LLC | 29,411 | $313,000 | 100.00% |
| Founders Fund VII Management, LLC | 3,773,530 | $40,188,000 | 93.02% |
| Gruss & Co., LLC | 363,778 | $3,874,000 | 26.99% |
| Founders Fund Growth Management, LLC | 407,017 | $4,334,000 | 12.66% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $44,387,000 | 5.09% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $43,719,000 | 5.06% |
| Intellectus Partners, LLC | 1,089,755 | $11,606,000 | 3.99% |
| ArchPoint Investors | 630,326 | $6,713,000 | 2.66% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $607,000 | 1.49% |
| Orbimed Advisors | 4,180,768 | $44,525,000 | 0.81% |